Moose, Yes, that lag time after Roth was interesting. I figured it may have been due to the overhang from the recent PIPE, plus Wall St doesn't follow Cortex like we do and it took them a while to catch on to what Stoll said at Roth. It was frustrating to watch since for several hours the next day one could have loaded up big at $1.20-1.30 no problem. I thought there was a fair chance the electron microscope would show some early cellular changes, but I should have at least had the funds in place and ready just in case the results were clean. Big oversight on my part.
I'd say the pre-decision "easy money" move still has a way to go before running out of steam. I'm figuring it stabilizes into a trading range somewhere in the $3s and goes sideways for a while. I missed the boat bigtime, but my funds will eventually be in place just in case there's a pre-decision shakeout opportunity or something. I've decided not to be long through the FDA decision period though, at least not with much. The ~15% meltdown scenario is still there for the FDA decision, regardless of what our hopes/expectations are. With my luck, having missed the easy triple from $1.20 to $3.60, I'll catch the 70% collapse. That would just about cap off my illustrious career as a stock speculator.
AI
Market Data 
Markets 
